Provectus Biopharmaceuticals (PVCT) Operating Expenses (2010 - 2026)
Provectus Biopharmaceuticals' Operating Expenses was $938,678 in Q2 2026, down 49.5% from $1.86 million a year earlier.
Powered by 
Analysis
Provectus Biopharmaceuticals (PVCT) Operating Expenses (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Provectus Biopharmaceuticals' Operating Expenses was $5.19 million through Jun 30, 2026, down 21.9% year-over-year; for FY2025, it came in at $5.63 million, up 9.3% from FY2024.
- Operating Expenses shows a five-year compound annual growth rate of 2.6% (FY2020 to FY2025).
- In earlier years, Operating Expenses was $5.15 million in FY2024 (+48.9%), $3.46 million in FY2023 (-21.7%), $4.42 million in FY2022 (-5.5%) and $4.67 million in FY2021 (-5.9%).
- The Q2 2026 figure marks the lowest quarterly Operating Expenses since Q1 2024.
- Compared with a year earlier, Operating Expenses was higher in five of the last seven quarters, with growth averaging 50.8%.
- The best year-over-year quarter for Operating Expenses over five years was Q4 2024 (growth of 223.6%); the worst was Q4 2025 (a decline of 52.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 7.95 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 11.12 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 10.56 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 12.80 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 6.09 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 9.70 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 6.54 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 18.20 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 6.68 Bn |
| 10 | Provectus Biopharmaceuticals | 21.01 Mn | 19.10 Mn | - | 938,678.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 938,678.00 |
| Dec 31, 2025 | 1.12 Mn |
| Sep 30, 2025 | 1.28 Mn |
| Jun 30, 2025 | 1.86 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | 2.35 Mn |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 685,337.00 |
| Dec 31, 2023 | 725,796.00 |
| Sep 30, 2023 | 783,881.00 |
| Jun 30, 2023 | 962,045.00 |
| Mar 31, 2023 | 987,238.00 |
| Dec 31, 2022 | 848,556.00 |
| Sep 30, 2022 | 981,079.00 |
| Jun 30, 2022 | 1.40 Mn |
| Mar 31, 2022 | 1.19 Mn |
| Dec 31, 2021 | 1.22 Mn |
| Sep 30, 2021 | 1.05 Mn |
| Jun 30, 2021 | 1.22 Mn |
API Access
Provectus Biopharmaceuticals Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-expenses&ticker=PVCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-expenses", "ticker": "PVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-expenses&ticker=PVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();